The Latest Cardiac and Vascular News
LAVAL, Quebec–(BUSINESS WIRE)–Altasciences is proud to have conducted preclinical studies for Verve Therapeutics that support the development and advancement of Verve’s gene editing approach to treating cardiovascular diseases. Altasciences’ Seattle team performed intravenous preclinical studies, including supporting analyses of pharmacodynamic markers and whole liver DNA editing, in non-human primates, that show […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a commercial scale supply agreement for the production of bentracimab, PhaseBio’s […]
Organizations to develop roadmap for hospitals, health systems and practices to improve clinical, financial and operational performance while transforming patient care Amsterdam, the Netherlands and Washington, D.C., U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, the American College of Cardiology (ACC), whose mission is to transform […]
TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. has earned a top award for XR R&F service according to data gathered during IMV’s 2020 ServiceTrak customer surveys. The award is given to imaging system providers that receive the highest percentage of highly satisfied customer responses. “It is an honor to add this […]
WARREN, N.J., March 11, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the fourth quarter and year ended December 31, 2020. “Bellerophon continues […]
New educational app from the leading cardiopulmonary digital health company offers clinical screening resources and real world application on identifying heart and lung abnormalities OAKLAND, Calif., March 11, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced the launch of its clinical education initiative. Eko Academy, a free […]
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food & Drug Administration (FDA) has granted expanded access approval for the administration of Longeveron’s investigational cell […]
NETANYA, Israel, March 10, 2021 / PRNewswire / – Perflow Medical, an innovative privately held Israel- based neurovascular treatment solutions company, announced today that it has launched the Cascade ™ 17 non-occlusive remodeling network on the European market . Expanding the Cascade family of products, the Cascade 17 optimizes non-occlusive support of tortuous and distal vessel anatomy during coil […]
– Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹ – Long-term results highlight GORE® CARDIOFORM Septal Occluder can be trusted for patient safety and effective defect closure. FLAGSTAFF, Ariz., March […]
Cloud-Based ECG Service Provides Continuous Monitoring and Full Disclosure Reports for Clinical Diagnostics SAN FRANCISCO, March 11, 2021 /PRNewswire/ — Qardio, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510k clearance for its QardioCore ambulatory ECG device. QardioCore will initially be marketed for holter monitoring applications, for use with […]
